Recital 42, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

This is reflected in the Parties’ switching data. Between 2020 and 2022,

Novozymes customers amounting to [percentage] of its sales of non-GM produced lactase in 2020 switched to buying GM produced lactase from Novozymes60 while [number] of Novozymes’ customers who purchased GM produced lactase in 2020 switched to Novozymes’ GM produced lactase.61 A similar pattern exists for Chr.

Hansen customers. The analysis finds switching in both directions although the switching from non-GM to GM produced lactase is higher; in particular, the analysis finds that [percentage] of Chr. Hansen customers in 2020 who were buying non-GM produced lactase have fully or partially switched to buying GM produced lactase in 2022. The analysis also finds that [percentage] of Chr. Hansen customers who were buying the GM product in 2020 have fully or partially switched to buying non-GM in 2022.62